G. K. Adams
- Physiology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 5%
- Immunology and Allergy top 1%
- Molecular Biology
- Co-authors
- Lawrence M. LichtensteinWilliam KreutnerRobert W. EganRobert P. SchleimerEdward S. SchulmanStephen P. PetersDonald W. MacGlashanArthur S. Watnick
- Topics
- Asthma and respiratory diseases (26 papers)Inhalation and Respiratory Drug Delivery (10 papers)Mast cells and histamine (9 papers)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
G. K. Adams
49 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 124
- Physiology 1.7k
- Pulmonary and Respiratory Medicine 870
- Immunology 725
- Immunology and Allergy 576
- Molecular Biology 276
Countries citing papers authored by G. K. Adams
This map shows the geographic impact of G. K. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. K. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. K. Adams more than expected).
Fields of papers citing papers by G. K. Adams
This network shows the impact of papers produced by G. K. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. K. Adams. The network helps show where G. K. Adams may publish in the future.
Co-authorship network of co-authors of G. K. Adams
This figure shows the co-authorship network connecting the top 25 collaborators of G. K. Adams. A scholar is included among the top collaborators of G. K. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. K. Adams. G. K. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 185 | |
| 3 | 254 | |
| 4 | 165 | |
| 5 | 184 | |
| 6 | 189 | |
| 7 | 42 | |
| 8 | 10 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | 56 | |
| 12 | 22 | |
| 13 | 3 | |
| 14 | 54 | |
| 15 | 6 | |
| 16 | Comparative studies of human basophils and mast cells. | 93 |
| 17 | Origin of PGF2 alpha production following anaphylactic challenge of human lung. | 3 |
| 18 | 23 | |
| 19 | 4 | |
| 20 | 3 |
About G. K. Adams
G. K. Adams is a scholar working on Immunology and Allergy, Physiology and Endocrine and Autonomic Systems, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (26 papers), Inhalation and Respiratory Drug Delivery (10 papers) and Mast cells and histamine (9 papers). The work is most often cited by research in Immunology and Allergy (576 citations), Physiology (1.7k citations) and Immunology (725 citations). G. K. Adams has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Lawrence M. Lichtenstein, William Kreutner, Robert W. Egan, Robert P. Schleimer, Edward S. Schulman, Stephen P. Peters, Donald W. MacGlashan, Arthur S. Watnick, Donald F. Proctor and Richard W. Chapman. Their work appears in journals such as Nature, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.